Daomin Tablet 850 mg contains Metformin Hydrochloride, a widely prescribed oral antidiabetic agent for the management of type 2 diabetes mellitus. Belonging to the biguanide class, Metformin is effective in lowering blood sugar levels by improving the body’s sensitivity to insulin and reducing glucose production in the liver. Unlike other antidiabetic medications, it does not stimulate insulin secretion, thereby minimizing the risk of hypoglycemia. Daomin Tablet 850 mg is suitable for adults and adolescents over 10 years of age and is often recommended as a first-line therapy for type 2 diabetes, especially in patients with obesity or insulin resistance.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Metformin Hydrochloride 850 mg

• Dosage Form: Oral tablet

• Route of Administration: Oral

Mechanism of Action

Metformin controls blood glucose through multiple mechanisms:

1. Reduction of hepatic glucose production: Metformin inhibits gluconeogenesis in the liver, which reduces fasting blood sugar levels.

2. Improved insulin sensitivity: Enhances glucose uptake in skeletal muscle and adipose tissue, increasing the body’s responsiveness to insulin.

3. Decreased intestinal glucose absorption: Moderately reduces glucose absorption from the gastrointestinal tract.

Because it does not promote insulin secretion, Metformin is associated with a low risk of hypoglycemia when used as monotherapy.

Indications

Daomin Tablet 850 mg is indicated for:

• Management of type 2 diabetes mellitus in adults and adolescents above 10 years

• Patients who do not achieve adequate glycemic control through diet and exercise alone

• Use as monotherapy or in combination with other oral antidiabetic agents or insulin

• Obese patients with insulin resistance or metabolic syndrome

• Prevention of long-term diabetic complications such as cardiovascular disease, nephropathy, neuropathy, and retinopathy

Dosage and Administration

• Starting dose: Usually 850 mg once daily with meals to reduce gastrointestinal side effects

• The dose may be gradually increased based on blood sugar levels, up to a maximum of 2,000–2,500 mg per day in divided doses

• Swallow tablets whole with water; do not crush or chew extended-release formulations

• Maintain a consistent diet, exercise, and monitoring routine for optimal results

• Regular monitoring of blood glucose is essential for dose adjustment and treatment effectiveness

Contraindications

Daomin Tablet 850 mg should not be used in:

• Patients with hypersensitivity to Metformin or biguanides

• Severe renal impairment or acute kidney injury

• Conditions associated with hypoxia, such as heart failure or respiratory insufficiency

• Hepatic impairment or chronic alcohol abuse

• Diabetic ketoacidosis or lactic acidosis

Precautions and Warnings

• Monitor renal function regularly to minimize the risk of lactic acidosis

• Use cautiously in elderly patients or those with risk factors for lactic acidosis

• Discontinue Metformin prior to radiologic procedures involving iodinated contrast agents

• Inform your doctor about other medications to prevent potential drug interactions

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Daomin Tablet is generally well tolerated. Common side effects include:

• Gastrointestinal disturbances: nausea, vomiting, diarrhea, and abdominal discomfort

• Mild metallic taste

• Rare but serious: lactic acidosis, particularly in patients with renal impairment

Storage

Store below 30°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.

Conclusion

Daomin Tablet 850 mg provides effective blood glucose control in patients with type 2 diabetes mellitus. By improving insulin sensitivity and reducing hepatic glucose production, it helps maintain stable blood sugar levels and reduces the risk of long-term diabetic complications. When used in combination with diet, exercise, and regular monitoring, Daomin Tablet 850 mg is a reliable, safe, and effective option for managing type 2 diabetes under medical supervision.